Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.75B |
| 2 |
Walmart Inc
WMT
|
+$3.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.42B |
| 4 |
Broadcom
AVGO
|
+$943M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$785M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$572M |
| 2 |
NVIDIA
NVDA
|
+$566M |
| 3 |
Apple
AAPL
|
+$554M |
| 4 |
AbbVie
ABBV
|
+$455M |
| 5 |
Bank of America
BAC
|
+$411M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.52% |
| 2 | Healthcare | 7.46% |
| 3 | Financials | 6.74% |
| 4 | Industrials | 6.14% |
| 5 | Consumer Discretionary | 4.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
PUT
Ares Management
ARES
$28.9B
| $1.12M | ﹤0.01% |
6,900
-700
| -9% | -$109K |
|
4302
Inseego
INSG
$114M
| $1.11M | ﹤0.01% |
+108,513
| New | +$1.41M |
|
4303
Interface
TILE
$1.99B
| $1.11M | ﹤0.01% |
39,859
-95,121
| -70% | -$2.59M |
|
4304
Kamada
KMDA
$412M
| $1.11M | ﹤0.01% |
157,610
-71,124
| -31% | -$492K |
|
|
RAC.U
4305
Rithm Acquisition Corp Units
RAC.U
| $1.11M | ﹤0.01% |
103,095
| – | – |
|
4306
Archer Daniels Midland
ADM
$38.2B
| $1.11M | ﹤0.01% |
19,238
-133,613
| -87% | -$7.98M |
|
4307
PACS Group
PACS
$7.28B
| $1.11M | ﹤0.01% |
28,796
-177,859
| -86% | -$3.9M |
|
|
FLOC
4308
Flowco Holdings
FLOC
$855M
| $1.1M | ﹤0.01% |
58,809
-207,266
| -78% | -$3.46M |
|
4309
CALL
Huntington Bancshares
HBAN
$34.4B
| $1.1M | ﹤0.01% |
+63,500
| New | +$1.04M |
|
4310
CTS Corp
CTS
$1.83B
| $1.1M | ﹤0.01% |
25,661
-60,573
| -70% | -$2.54M |
|
4311
CALL
Sempra
SRE
$57.9B
| $1.09M | ﹤0.01% |
12,400
-57,900
| -82% | -$5.27M |
|
|
GGN
4312
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$766M
| $1.09M | ﹤0.01% |
+212,098
| New | +$1.07M |
|
|
PDT
4313
John Hancock Premium Dividend Fund
PDT
$634M
| $1.09M | ﹤0.01% |
+86,098
| New | +$1.11M |
|
4314
Syndax Pharmaceuticals
SNDX
$1.69B
| $1.09M | ﹤0.01% |
51,937
-994,519
| -95% | -$17.3M |
|
4315
NB Bancorp
NBBK
$1.01B
| $1.09M | ﹤0.01% |
54,866
-488,416
| -90% | -$9.29M |
|
4316
Invesco China Technology ETF
CQQQ
$3.03B
| $1.09M | ﹤0.01% |
+20,900
| New | +$1.14M |
|
4317
PUT
Live Nation Entertainment
LYV
$40.6B
| $1.08M | ﹤0.01% |
+7,600
| New | +$1.09M |
|
|
JBS
4318
PUT
JBS N.V.
JBS
$46.1B
| $1.08M | ﹤0.01% |
75,000
-75,000
| -50% | -$1.03M |
|
|
QNRX
4319
Quoin Pharmaceuticals
QNRX
$8.94M
| $1.08M | ﹤0.01% |
+74,817
| New | +$1.02M |
|
4320
Park National Corp
PRK
$3.76B
| $1.08M | ﹤0.01% |
7,082
-2,153
| -23% | -$339K |
|
4321
BioCryst Pharmaceuticals
BCRX
$2.28B
| $1.07M | ﹤0.01% |
137,626
-323,321
| -70% | -$2.34M |
|
4322
CALL
Frontier Group Holdings
ULCC
$1.55B
| $1.07M | ﹤0.01% |
+227,800
| New | +$1.01M |
|
4323
ProFrac Holding
ACDC
$731M
| $1.07M | ﹤0.01% |
275,012
-42,434
| -13% | -$173K |
|
4324
Costamare
CMRE
$1.88B
| $1.07M | ﹤0.01% |
67,702
+49,721
| +277% | +$687K |
|
4325
PUT
Universal Health Services
UHS
$10.2B
| $1.07M | ﹤0.01% |
4,900
-3,700
| -43% | -$818K |
|
Similar funds
Millennium Management's Q4 2025 Portfolio in Review
As of Q4 2025, Millennium Management held 6,645 positions worth $238B, up 1.5% from $234B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Millennium Management's Q4 2025 filing shows 668 new, 2,203 increased, 2,701 reduced and 696 closed positions. Its largest new stake was iShares Russell 1000 ETF: 455,129 shares worth $170M. The largest sale was Microsoft, an estimated $572M.
By sector, the portfolio is most concentrated in Technology at 9.5% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Financials.
- Millennium Management's largest Q4 2025 buy was iShares Russell 1000 ETF: 455,129 shares worth $170M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $4.75B increase.
- Millennium Management's biggest Q4 2025 reduction was Microsoft, cutting an estimated $572M.
- Millennium Management fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Millennium Management's ten largest holdings make up 19% of its $238B portfolio in Q4 2025.
- Millennium Management opened 668 new positions and closed 696 in Q4 2025.
- Millennium Management's portfolio value rose 1.5% quarter-over-quarter to $238B.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.